Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology ...

We’re kicking off a brand-new monthly tradition! Each month, the editors of LCGC International will select the Top 10 ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

The crypto market is on the brink of another major rally, and experienced investors know that positioning early is the key to ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 10.05%, which has investors questioning if this is right time to buy.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.

In this article, we are going to take a look at where Conduit Pharmaceuticals Inc. (NASDAQ:CDT) stands against the other AI ...

Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Cullinan Therapeutics in a report released ...